Compare Tempus AI (TEM) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance

Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.

Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.

VYMI trades at $100.23, down 1.11% with a bearish technical signal from moving averages. The ETF offers international diversification with a focus on high dividend yields, recently announcing a $0.82 dividend payment scheduled for September 2026. Recent institutional buying activity from firms like Envestnet and Corient Private Wealth indicates growing institutional interest despite the current technical weakness.

The outlook remains constructive given VYMI's strong historical performance (14.13% 5-year average annual return) and dividend growth potential. Key risks include global market volatility and currency fluctuations affecting international holdings. The ETF's financials-heavy portfolio (43.6% allocation) positions it to benefit from rising global interest rates, though this concentration also increases sector-specific risk exposure.